Tomas Björklund
31 – 40 of 52
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
Dysregulated dopamine storage increases the vulnerability to alpha-synuclein in nigral neurons
- Contribution to journal › Article
-
Mark
Design of a Single AAV Vector for Coexpression of TH and GCH1 to Establish Continuous DOPA Synthesis in a Rat Model of Parkinson's Disease.
- Contribution to journal › Article
- 2011
-
Mark
Mutant huntingtin causes metabolic imbalance by disruption of hypothalamic neurocircuits.
- Contribution to journal › Article
-
Mark
Gene therapy for Parkinson's disease shows promise.
- Contribution to journal › Article
- 2010
-
Mark
Differential Transduction Following Basal Ganglia Administration of Distinct Pseudotyped AAV Capsid Serotypes in Nonhuman Primates
- Contribution to journal › Article
-
Mark
A General Chemical Method to Regulate Protein Stability in the Mammalian Central Nervous System
- Contribution to journal › Article
-
Mark
Optimized adeno-associated viral vector-mediated striatal DOPA delivery restores sensorimotor function and prevents dyskinesias in a model of advanced Parkinson's disease.
- Contribution to journal › Article
-
Mark
Gene therapy for Parkinson's disease.
- Contribution to journal › Article
-
Mark
Gene therapy for dopamine replacement.
- Contribution to journal › Scientific review
- 2009
-
Mark
Dose Optimization for Long-term rAAV-mediated RNA Interference in the Nigrostriatal Projection Neurons.
- Contribution to journal › Article
